Johanna Laukkarinen

Medicine & Life Sciences

1. Chronic Pancreatitis 100%
2. Pancreatic Neoplasms 51%
3. Finland 32%
4. Palliative Care 27%
5. Multicenter Studies 26%
6. Appendicitis 24%
7. Insulinoma 24%
8. Acinar Cells 22%
9. Observational Studies 22%
10. Pancreatitis 22%
11. Retrospective Studies 20%
12. Exocrine Pancreatic Insufficiency 19%
13. Morbidity 19%
14. Ertapenem 17%
15. Quality of Life 16%
16. Pain 16%
17. Stents 16%
18. Neoplasms 15%
19. Endoscopic Retrograde Cholangiopancreatography 15%
20. Survival 15%
21. Kazal Pancreatic Trypsin Inhibitor 15%
22. Pancreatic Stellate Cells 15%
23. Bile Ducts 14%
24. Urokinase Plasminogen Activator Receptors 14%
25. Exocrine Pancreas 14%
26. Meta-Analysis 14%
27. Mortality 14%
28. Systematic Reviews 14%
29. Levofloxacin 14%
30. Pancreatic Cyst 13%
31. Volatile Organic Compounds 13%
32. Gastric Outlet Obstruction 13%
33. Surgeons 13%
34. Common Bile Duct 13%
35. Endoscopic Sphincterotomy 13%
36. Equivalence Trials 12%
37. Pancreatic Fistula 12%
38. Bile 12%
39. Anti-Bacterial Agents 12%
40. Moxifloxacin 12%
41. Appendectomy 12%
42. Alcohols 12%
43. Proof of Concept Study 12%
44. Sarcopenia 11%
45. Pathologic Constriction 11%
46. Adenocarcinoma 11%
47. Pancreaticoduodenectomy 11%
48. Learning Curve 11%
49. Tertiary Care Centers 11%
50. Gastric Bypass 11%